Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Verubulin

Generic Name: Verubulin

Drug Type: Small Molecule

Chemical Formula: C_₁₇H_₁₇N_₃O

CAS Number: 827031-83-4

Unique Ingredient Identifier: X97O9FTB92

Overview

Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.

Background

Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.

Indication

Investigated for use/treatment in brain cancer, lung cancer, melanoma, and solid tumors.

Associated Conditions

No associated conditions information available.

Clinical Trials

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2

Completed

Posted: 2011/01/28

Sponsor:Myrexis Inc.

ID:NCT01285414

Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme

Phase 2

Completed

Posted: 2009/05/05

Sponsor:Myrexis Inc.

ID:NCT00892931

Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors

Phase 1

Completed

Posted: 2006/11/01

Sponsor:Myrexis Inc.

ID:NCT00394446

Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases

Phase 1

Completed

Posted: 2006/10/31

Sponsor:Myrexis Inc.

ID:NCT00393965

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy